Full-Time

QO Lab Analyst IV

Confirmed live in the last 24 hours

Zoetis

Zoetis

5,001-10,000 employees

No salary listed

Mid, Senior

Kalamazoo, MI, USA

Category
Lab & Research
Life Sciences
Requirements
  • AAS, BA/BS, or MS in Chemistry, Biochemistry, or related science
  • Ability to follow written procedures
  • Good laboratory technique to avoid cross-contamination or misidentification of samples
  • High productivity and the ability to multi-task
  • Attention to detail
  • Demonstrates flexibility/agility and engagement in a changing environment
Responsibilities
  • Performs, documents and record checks qualitative and quantitative assays on samples
  • Interprets and evaluates data for accuracy, precision, trends, and potential GMP impact
  • Recommends and executes process improvements to continually improve laboratory performance
  • May train others as skills and knowledge allow
  • Troubleshoot instrumentation as skills and knowledge allow
  • Participates in laboratory investigations as required
  • May participate in manufacturing QC support such as cleaning verification
Desired Qualifications
  • Related experience in Quality Control is preferred but not required
  • Preferred experience includes HPLC, Dissolution, use of Empower3 software and prior experience with GMP documentation
  • Willingness and ability to learn
  • Ability to work in a team environment

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Zoetis' focus on precision livestock farming aligns with AI-driven cattle health monitoring.
  • The development of mRNA vaccines complements Zoetis' existing vaccine portfolio, boosting innovation.
  • Sustainability trends in animal agriculture present opportunities for Zoetis to develop new health products.

What critics are saying

  • Emerging biotech firms like Elanco could impact Zoetis' market share in animal health.
  • Regulatory changes on antibiotic use in livestock may affect Zoetis' product offerings.
  • Volatility in raw material prices could increase production costs for Zoetis.

What makes Zoetis unique

  • Zoetis leads in animal health with a strong vaccine portfolio since its Pfizer spinoff.
  • The company is expanding digital health offerings, aligning with telemedicine trends in veterinary care.
  • Zoetis is exploring blockchain for supply chain management, enhancing product traceability and safety.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

PYMNTS
Apr 17th, 2025
How To Manage Risks When Employees Use Ai Secretly For Work

Employees who use generative artificial intelligence tools in the workplace without company approval or oversight — a practice known as “bring your own AI’ or BYOAI — could introduce risks into the enterprise, according to MIT researchers. “Make no mistake, I’m not talking theory here,” said Nick van der Meulen, a research scientist at MIT’s [] The post How to Manage Risks When Employees Use AI Secretly for Work appeared first on PYMNTS.com.

MarketBeat
Mar 11th, 2025
Clare Market Investments LLC Makes New $670,000 Investment in Zoetis Inc. (NYSE:ZTS)

Clare Market Investments LLC makes new $670,000 investment in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Mar 10th, 2025
Raymond James Financial Inc. Makes New $196.65 Million Investment in Zoetis Inc. (NYSE:ZTS)

Raymond James Financial Inc. makes new $196.65 million investment in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Feb 27th, 2025
World Equity Group Inc. Invests $342,000 in Zoetis Inc. (NYSE:ZTS)

World Equity Group Inc. invests $342,000 in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Feb 22nd, 2025
Tandem Investment Advisors Inc. Invests $32.19 Million in Zoetis Inc. (NYSE:ZTS)

Tandem Investment Advisors Inc. invests $32.19 million in Zoetis Inc. (NYSE:ZTS).